We are live on !
Find out more
Moors & Cabot Portfolio holdings
AUM
$2.65B
Turnover
11.39%
1-Year Est. Return
29.91%
Moors & Cabot is a full-service wealth management firm that dates to 1890, when John F. Moors and Charles Cabot started it in Boston. The two founders set it up to manage their own families' investments and those of their friends. It offers investment management, planning and advice for major life events, and runs its own insurance and annuities department. Michael Hildreth, its president and chief executive, is also one of its owners.
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+29.91%
3 Year Est. Return
+133.86%
5 Year Est. Return
+167.35%
10 Year Est. Return
+483.58%
AUM
$608M
AUM Growth
+$9.37M
(+1.6%)
Cap. Flow
-$4.51M
Cap. Flow % of AUM
Cap. Flow %
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
610
New
61
Increased
197
Reduced
243
Closed
73
Avg Time Held
Equity + Options
1.9
years
Top 10 Avg Time Held
Equity + Options
2.2
years
Top 20 Avg Time Held
Equity + Options
2
years
Avg Time Held Equity only
1.9
years
Top 10 Avg Time Held Equity only
2.2
years
Top 20 Avg Time Held Equity only
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.08M |
| 2 |
Accenture
ACN
|
+$2.05M |
| 3 |
Microsoft
MSFT
|
+$1.3M |
| 4 |
Tractor Supply
TSCO
|
+$853K |
| 5 |
Qualcomm
QCOM
|
+$796K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Psychemedics Corporation
PMD
|
+$3.07M |
| 2 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$1.39M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$1.05M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$980K |
| 5 |
SHPG
Shire pic
SHPG
|
+$971K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.33% |
| 2 | Healthcare | 14.12% |
| 3 | Industrials | 12.28% |
| 4 | Consumer Staples | 9.86% |
| 5 | Miscellaneous | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
GE Aerospace
GE
$348B
| $14.1M | 2.31% |
92,812
+1,224
| +1% | +$178K |
2014 Q1
11 quarters
|
|
2
ExxonMobil
XOM
$672B
| $13.6M | 2.24% |
150,415
+3,299
| +2% | +$288K |
2014 Q1
11 quarters
|
|
3
Johnson & Johnson
JNJ
$679B
| $13.2M | 2.17% |
114,004
+734
| +0.6% | +$84.8K |
2014 Q1
11 quarters
|
|
4
Procter & Gamble
PG
$390B
| $10.9M | 1.79% |
129,543
-1,337
| -1% | -$114K |
2014 Q1
11 quarters
|
|
5
AT&T
T
$147B
| $9.9M | 1.64% |
308,348
+1,388
| +0.5% | +$41K |
2014 Q1
11 quarters
|
|
6
Verizon
VZ
$191B
| $9.6M | 1.59% |
180,479
-7,165
| -4% | -$358K |
2014 Q1
11 quarters
|
|
7
Enterprise Products Partners
EPD
$79.1B
| $9.6M | 1.59% |
356,254
-2,117
| -0.6% | -$55.2K |
2014 Q1
11 quarters
|
|
8
Apple
AAPL
$5.1T
| $9.43M | 1.55% |
325,344
+4,688
| +1% | +$133K |
2014 Q1
11 quarters
|
|
|
9
DELISTED
Psychemedics Corporation
PMD
| $8.93M | 1.47% |
361,893
-137,076
| -27% | -$3.07M |
2014 Q1
11 quarters
|
|
10
PepsiCo
PEP
$193B
| $8.76M | 1.44% |
83,923
-804
| -0.9% | -$84.2K |
2014 Q1
11 quarters
|
|
11
Chevron
CVX
$411B
| $7.03M | 1.16% |
59,463
-455
| -0.8% | -$49.5K |
2014 Q1
11 quarters
|
|
|
12
Microsoft
MSFT
$4.05T
| $6.89M | 1.13% |
111,005
+21,567
| +24% | +$1.3M |
2014 Q1
11 quarters
|
|
13
BP
BP
$115B
| $6.34M | 1.04% |
198,434
-18,072
| -8% | -$544K |
2014 Q1
11 quarters
|
|
14
Pfizer
PFE
$167B
| $6.3M | 1.04% |
205,206
+10,556
| +5% | +$322K |
2014 Q1
11 quarters
|
|
|
MMP
15
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $5.64M | 0.93% |
74,631
-695
| -0.9% | -$48.7K |
2014 Q1
11 quarters
|
|
16
Intel
INTC
$316B
| $5.58M | 0.92% |
153,839
-7,686
| -5% | -$275K |
2014 Q1
11 quarters
|
|
17
JPMorgan Chase
JPM
$908B
| $5.51M | 0.91% |
63,830
-8,055
| -11% | -$614K |
2014 Q1
11 quarters
|
|
18
Walt Disney
DIS
$206B
| $5.02M | 0.83% |
48,245
+3,015
| +7% | +$294K |
2014 Q1
11 quarters
|
|
19
RTX Corp
RTX
$265B
| $4.72M | 0.78% |
68,548
-2,646
| -4% | -$175K |
2014 Q1
11 quarters
|
|
20
Williams Companies
WMB
$83.1B
| $4.55M | 0.75% |
146,374
-8,444
| -5% | -$254K |
2014 Q1
11 quarters
|
|
21
Eaton
ETN
$140B
| $4.5M | 0.74% |
67,074
-762
| -1% | -$50K |
2014 Q1
11 quarters
|
|
22
Merck
MRK
$367B
| $4.35M | 0.72% |
77,238
+164
| +0.2% | +$9.6K |
2014 Q1
11 quarters
|
|
|
ETP
23
DELISTED
Energy Transfer Partners L.p.
ETP
| $4.2M | 0.69% |
117,110
+1,080
| +0.9% | +$38.5K |
2014 Q1
11 quarters
|
|
24
Bristol-Myers Squibb
BMY
$127B
| $4.19M | 0.69% |
71,421
+11,765
| +20% | +$643K |
2014 Q1
11 quarters
|
|
25
CVS Health
CVS
$109B
| $4.18M | 0.69% |
52,766
+870
| +2% | +$70.4K |
2014 Q1
11 quarters
|
|
Similar funds
FFH
Moors & Cabot's Q4 2016 Portfolio in Review
As of Q4 2016, Moors & Cabot held 610 positions worth $608M, up 1.6% from $598M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Moors & Cabot's Q4 2016 filing shows 61 new, 197 increased, 243 reduced and 73 closed positions. Its largest new stake was Accenture: 17,254 shares worth $2.02M. The largest sale was Psychemedics Corporation, an estimated $3.07M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Moors & Cabot's largest Q4 2016 buy was Accenture: 17,254 shares worth $2.02M.
- Moors & Cabot added most to Eli Lilly in Q4 2016, an estimated $2.08M increase.
- Moors & Cabot's biggest Q4 2016 reduction was Psychemedics Corporation, cutting an estimated $3.07M.
- Moors & Cabot fully exited State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q4 2016, selling an estimated $1.39M.
- Moors & Cabot's ten largest holdings make up 18% of its $608M portfolio in Q4 2016.
- Moors & Cabot opened 61 new positions and closed 73 in Q4 2016.
- Moors & Cabot's portfolio value rose 1.6% quarter-over-quarter to $608M.
Based on Moors & Cabot's 13F filing for Q4 2016, filed 13 Feb 2017.